Neutrophil-Lymphocyte Ratio (NLR) and Platelet-Lymphocyte Ratio (PLR) as neuroinflammatory biomarkers in Amyotrophic Lateral Sclerosis (ALS) progression
Autor(a) principal: | |
---|---|
Data de Publicação: | 2022 |
Outros Autores: | , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Research, Society and Development |
Texto Completo: | https://rsdjournal.org/index.php/rsd/article/view/28073 |
Resumo: | Amyotrophic Lateral Sclerosis (ALS) is a rapidly progressing multisystemic and multifactorial neurodegenerative disease that affects upper and lower motor neurons. Neuroinflammation is an important factor in neurodegeneration, the increase of immune cells in the neural tissue and degranulation of these cells causes neuronal damage and death, thus playing an important role in ALS pathophysiology. Studies have sought to use the neutrophil-lymphocyte ratio (NLR) and the platelet-lymphocyte ratio (PLR) as biomarkers of the inflammatory response indicative of diagnosis, stratification, progression and response to treatment of several diseases, including neurodegenerative. Thus, the aim of this study was to evaluate NLR and PLR as possible biomarkers in the neurodegenerative process. This retrospective cross-sectional study was carried out with 43 ALS patients selected at the Dr. Henrique Santillo Rehabilitation and Readaptation Center (CRER), Goiânia, Goiás – Brazil. Neutrophil, platelet, and lymphocyte counts were collected from the patient's most recent hemogram. Statistical analysis was performed using SPSS software, version 26. The correlation between NLR and PLR according to clinical condition showed a significant difference in these parameters during the initial phase of ALS development (p=0.01), revealing a marked inflammatory, with subsequent decline as the disease progresses (p=0.06). Furthermore, the results indicated a moderate positive linear relationship between the two variables (r=0.57; p<0.001), showing a joint increase in these parameters. Therefore, NLR and PLR are important indicators of inflammation and can be useful due to their simplicity, high reproducibility and low-cost for routine use. |
id |
UNIFEI_68c2778b5153d0edcee92c8f77b611aa |
---|---|
oai_identifier_str |
oai:ojs.pkp.sfu.ca:article/28073 |
network_acronym_str |
UNIFEI |
network_name_str |
Research, Society and Development |
repository_id_str |
|
spelling |
Neutrophil-Lymphocyte Ratio (NLR) and Platelet-Lymphocyte Ratio (PLR) as neuroinflammatory biomarkers in Amyotrophic Lateral Sclerosis (ALS) progressionRelación neutrófilos-linfocitos (RNL) y relación plaquetas-linfocitos (RPL) como biomarcadores neuroinflamatorios en la progresión de la esclerosis lateral amiotrófica (ELA)Razão Neutrófilo-Linfócito (RNL) e Razão Plaqueta-Linfócito (RPL) como biomarcadores neuroinflamatórios na progressão da Esclerose Lateral Amiotrófica (ELA) Inflamação neurogênicaNeurodegeneraçãoAvaliação clínicaPrognóstico.Inflamación neurogénicaNeurodegeneraciónClasificación clínicaPronóstico.Neurogenic inflammationNeurodegenerationClinical ratingPrognosis.Amyotrophic Lateral Sclerosis (ALS) is a rapidly progressing multisystemic and multifactorial neurodegenerative disease that affects upper and lower motor neurons. Neuroinflammation is an important factor in neurodegeneration, the increase of immune cells in the neural tissue and degranulation of these cells causes neuronal damage and death, thus playing an important role in ALS pathophysiology. Studies have sought to use the neutrophil-lymphocyte ratio (NLR) and the platelet-lymphocyte ratio (PLR) as biomarkers of the inflammatory response indicative of diagnosis, stratification, progression and response to treatment of several diseases, including neurodegenerative. Thus, the aim of this study was to evaluate NLR and PLR as possible biomarkers in the neurodegenerative process. This retrospective cross-sectional study was carried out with 43 ALS patients selected at the Dr. Henrique Santillo Rehabilitation and Readaptation Center (CRER), Goiânia, Goiás – Brazil. Neutrophil, platelet, and lymphocyte counts were collected from the patient's most recent hemogram. Statistical analysis was performed using SPSS software, version 26. The correlation between NLR and PLR according to clinical condition showed a significant difference in these parameters during the initial phase of ALS development (p=0.01), revealing a marked inflammatory, with subsequent decline as the disease progresses (p=0.06). Furthermore, the results indicated a moderate positive linear relationship between the two variables (r=0.57; p<0.001), showing a joint increase in these parameters. Therefore, NLR and PLR are important indicators of inflammation and can be useful due to their simplicity, high reproducibility and low-cost for routine use.La esclerosis lateral amiotrófica (ELA) es una enfermedad neurodegenerativa multifactorial y multisistémica que progresa rápidamente y que afecta a las neuronas motoras superiores e inferiores. La neuroinflamación es un factor importante en la neurodegeneración, el aumento de células inmunitarias en el tejido neural y la desgranulación de estas células provoca daño y muerte neuronal, por lo que juega un papel importante en la fisiopatología de la ELA. Los estudios han buscado utilizar la relación neutrófilos-linfocitos (RNL) y la relación plaquetas-linfocitos (RPL) como biomarcadores de la respuesta inflamatoria indicativos del diagnóstico, estratificación, progresión y respuesta al tratamiento de varias enfermedades, incluidas las neurodegenerativas. Por lo tanto, el objetivo de este estudio fue evaluar RNL y RPL como posibles biomarcadores en el proceso neurodegenerativo. Este estudio transversal retrospectivo fue realizado con 43 pacientes con ELA seleccionados en el Centro de Rehabilitación y Readaptación Dr. Henrique Santillo (CRER), Goiânia, Goiás – Brasil. Los recuentos de neutrófilos, plaquetas y linfocitos se obtuvieron del análisis de sangre más reciente del pacientes. El análisis estadístico se realizó con el software SPSS, versión 26. La correlación entre RNL y RPL según la condición clínica mostró una diferencia significativa en estos parámetros durante la fase inicial del desarrollo de la ELA (p = 0,01), revelando un marcado cuadro inflamatorio, con un declive posterior con el avance de la enfermedad (p=0,06). Además, los resultados indicaron una relación lineal positiva moderada entre las dos variables (r=0,57; p<0,001), mostrando un aumento conjunto de estos parámetros. Por lo tanto, RNL y RPL son indicadores importantes de inflamación y pueden ser útiles debido a su simplicidad, alta reproducibilidad y bajo costo para uso rutinario.A Esclerose Lateral Amiotrófica (ELA) é uma doença neurodegenerativa multissistêmica e multifatorial de rápida progressão que afeta os neurônios motores superiores e inferiores. A neuroinflamação é um fator importante na neurodegeneração, o aumento de células imunes no tecido neural e a degranulação dessas células causam danos e morte neuronal, desempenhando assim um papel importante na fisiopatologia da ELA. Estudos têm buscado utilizar a razão neutrófilo-linfócito (RNL) e a razão plaqueta-linfócito (RPL) como biomarcadores da resposta inflamatória indicativos de diagnóstico, estratificação, progressão e resposta ao tratamento de diversas doenças, incluindo as neurodegenerativas. Assim, o objetivo deste estudo foi avaliar a RNL e a RPL como possíveis biomarcadores no processo neurodegenerativo. Este estudo transversal retrospectivo foi desenvolvido com 43 pacientes portadores de ELA selecionados no Centro de Reabilitação e Readaptação Dr. Henrique Santillo (CRER), Goiânia, Goiás – Brasil. A contagem de neutrófilos, plaquetas e linfócitos foi coletada do hemograma mais recente dos pacientes. A análise estatística foi realizada por meio do software SPSS, versão 26. A correlação entre RNL e RPL de acordo com a condição clínica, mostrou diferença significativa nesses parâmetros durante a fase inicial do desenvolvimento da ELA (p=0,01), revelando um quadro inflamatório acentuado, com posterior declínio com o avanço da doença (p=0,06). Além disso, os resultados indicaram uma relação linear positiva moderada entre as duas variáveis (r=0,57; p<0,001), mostrando um aumento em conjunto desses parâmetros. Portanto, a RNL e a RPL são importantes indicadores de inflamação e podem ser úteis devido à sua simplicidade, alta reprodutibilidade e baixo custo para uso rotineiro.Research, Society and Development2022-04-07info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/2807310.33448/rsd-v11i5.28073Research, Society and Development; Vol. 11 No. 5; e29611528073Research, Society and Development; Vol. 11 Núm. 5; e29611528073Research, Society and Development; v. 11 n. 5; e296115280732525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIenghttps://rsdjournal.org/index.php/rsd/article/view/28073/24575Copyright (c) 2022 Kamilla de Faria Santos; Rômulo Morais Azevedo; Caroline Christine Pincela da Costa; Dhiogo da Cruz Pereira Bento; Angela Adamski da Silva Reis; Rodrigo da Silva Santoshttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessSantos, Kamilla de Faria Azevedo, Rômulo Morais Costa, Caroline Christine Pincela da Bento, Dhiogo da Cruz Pereira Reis, Angela Adamski da Silva Santos, Rodrigo da Silva 2022-04-17T18:18:56Zoai:ojs.pkp.sfu.ca:article/28073Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2024-01-17T09:45:36.514629Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false |
dc.title.none.fl_str_mv |
Neutrophil-Lymphocyte Ratio (NLR) and Platelet-Lymphocyte Ratio (PLR) as neuroinflammatory biomarkers in Amyotrophic Lateral Sclerosis (ALS) progression Relación neutrófilos-linfocitos (RNL) y relación plaquetas-linfocitos (RPL) como biomarcadores neuroinflamatorios en la progresión de la esclerosis lateral amiotrófica (ELA) Razão Neutrófilo-Linfócito (RNL) e Razão Plaqueta-Linfócito (RPL) como biomarcadores neuroinflamatórios na progressão da Esclerose Lateral Amiotrófica (ELA) |
title |
Neutrophil-Lymphocyte Ratio (NLR) and Platelet-Lymphocyte Ratio (PLR) as neuroinflammatory biomarkers in Amyotrophic Lateral Sclerosis (ALS) progression |
spellingShingle |
Neutrophil-Lymphocyte Ratio (NLR) and Platelet-Lymphocyte Ratio (PLR) as neuroinflammatory biomarkers in Amyotrophic Lateral Sclerosis (ALS) progression Santos, Kamilla de Faria Inflamação neurogênica Neurodegeneração Avaliação clínica Prognóstico. Inflamación neurogénica Neurodegeneración Clasificación clínica Pronóstico. Neurogenic inflammation Neurodegeneration Clinical rating Prognosis. |
title_short |
Neutrophil-Lymphocyte Ratio (NLR) and Platelet-Lymphocyte Ratio (PLR) as neuroinflammatory biomarkers in Amyotrophic Lateral Sclerosis (ALS) progression |
title_full |
Neutrophil-Lymphocyte Ratio (NLR) and Platelet-Lymphocyte Ratio (PLR) as neuroinflammatory biomarkers in Amyotrophic Lateral Sclerosis (ALS) progression |
title_fullStr |
Neutrophil-Lymphocyte Ratio (NLR) and Platelet-Lymphocyte Ratio (PLR) as neuroinflammatory biomarkers in Amyotrophic Lateral Sclerosis (ALS) progression |
title_full_unstemmed |
Neutrophil-Lymphocyte Ratio (NLR) and Platelet-Lymphocyte Ratio (PLR) as neuroinflammatory biomarkers in Amyotrophic Lateral Sclerosis (ALS) progression |
title_sort |
Neutrophil-Lymphocyte Ratio (NLR) and Platelet-Lymphocyte Ratio (PLR) as neuroinflammatory biomarkers in Amyotrophic Lateral Sclerosis (ALS) progression |
author |
Santos, Kamilla de Faria |
author_facet |
Santos, Kamilla de Faria Azevedo, Rômulo Morais Costa, Caroline Christine Pincela da Bento, Dhiogo da Cruz Pereira Reis, Angela Adamski da Silva Santos, Rodrigo da Silva |
author_role |
author |
author2 |
Azevedo, Rômulo Morais Costa, Caroline Christine Pincela da Bento, Dhiogo da Cruz Pereira Reis, Angela Adamski da Silva Santos, Rodrigo da Silva |
author2_role |
author author author author author |
dc.contributor.author.fl_str_mv |
Santos, Kamilla de Faria Azevedo, Rômulo Morais Costa, Caroline Christine Pincela da Bento, Dhiogo da Cruz Pereira Reis, Angela Adamski da Silva Santos, Rodrigo da Silva |
dc.subject.por.fl_str_mv |
Inflamação neurogênica Neurodegeneração Avaliação clínica Prognóstico. Inflamación neurogénica Neurodegeneración Clasificación clínica Pronóstico. Neurogenic inflammation Neurodegeneration Clinical rating Prognosis. |
topic |
Inflamação neurogênica Neurodegeneração Avaliação clínica Prognóstico. Inflamación neurogénica Neurodegeneración Clasificación clínica Pronóstico. Neurogenic inflammation Neurodegeneration Clinical rating Prognosis. |
description |
Amyotrophic Lateral Sclerosis (ALS) is a rapidly progressing multisystemic and multifactorial neurodegenerative disease that affects upper and lower motor neurons. Neuroinflammation is an important factor in neurodegeneration, the increase of immune cells in the neural tissue and degranulation of these cells causes neuronal damage and death, thus playing an important role in ALS pathophysiology. Studies have sought to use the neutrophil-lymphocyte ratio (NLR) and the platelet-lymphocyte ratio (PLR) as biomarkers of the inflammatory response indicative of diagnosis, stratification, progression and response to treatment of several diseases, including neurodegenerative. Thus, the aim of this study was to evaluate NLR and PLR as possible biomarkers in the neurodegenerative process. This retrospective cross-sectional study was carried out with 43 ALS patients selected at the Dr. Henrique Santillo Rehabilitation and Readaptation Center (CRER), Goiânia, Goiás – Brazil. Neutrophil, platelet, and lymphocyte counts were collected from the patient's most recent hemogram. Statistical analysis was performed using SPSS software, version 26. The correlation between NLR and PLR according to clinical condition showed a significant difference in these parameters during the initial phase of ALS development (p=0.01), revealing a marked inflammatory, with subsequent decline as the disease progresses (p=0.06). Furthermore, the results indicated a moderate positive linear relationship between the two variables (r=0.57; p<0.001), showing a joint increase in these parameters. Therefore, NLR and PLR are important indicators of inflammation and can be useful due to their simplicity, high reproducibility and low-cost for routine use. |
publishDate |
2022 |
dc.date.none.fl_str_mv |
2022-04-07 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/28073 10.33448/rsd-v11i5.28073 |
url |
https://rsdjournal.org/index.php/rsd/article/view/28073 |
identifier_str_mv |
10.33448/rsd-v11i5.28073 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/28073/24575 |
dc.rights.driver.fl_str_mv |
https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Research, Society and Development |
publisher.none.fl_str_mv |
Research, Society and Development |
dc.source.none.fl_str_mv |
Research, Society and Development; Vol. 11 No. 5; e29611528073 Research, Society and Development; Vol. 11 Núm. 5; e29611528073 Research, Society and Development; v. 11 n. 5; e29611528073 2525-3409 reponame:Research, Society and Development instname:Universidade Federal de Itajubá (UNIFEI) instacron:UNIFEI |
instname_str |
Universidade Federal de Itajubá (UNIFEI) |
instacron_str |
UNIFEI |
institution |
UNIFEI |
reponame_str |
Research, Society and Development |
collection |
Research, Society and Development |
repository.name.fl_str_mv |
Research, Society and Development - Universidade Federal de Itajubá (UNIFEI) |
repository.mail.fl_str_mv |
rsd.articles@gmail.com |
_version_ |
1797052709056020480 |